Parasol Pharmaceuticals: Difference between revisions

From IxWiki
Jump to navigation Jump to search
mNo edit summary
Tag: 2017 source edit
mNo edit summary
Line 1: Line 1:
{{NonCanon}}
{{Infobox company
{{Infobox company
| name = Parasol Pharmaceuticals S.p.A
| name = Parasol Pharmaceuticals S.p.A
Line 31: Line 32:
| subsid = Usan Uiyagpum, DeSantoro Tecnico
| subsid = Usan Uiyagpum, DeSantoro Tecnico
| website =
| website =
}}
}}'''Parasol Pharmaceutical S.p.A''', commonly known as '''Parasol Pharma''', is an Acirian multinational healthcare company that operates worldwide in the pharmaceutical, chemical and biotechnological fields since its founding in 1927. It is currently ran by Salvano Ombrello, the son of the founder of the company. Parasol Pharma is headquartered in Soleramo, [[Aciria]], with its biotechnical division headquartered in [[Trossera]], following the acquisition of DeSantoro Tecnico in 1997, with the majority of manufacturing and R&D sites are located in Aciria. In 2030 the company was acquired by [[Daxia]]'s [[Opdo Corporation]], one of [[Audonia]]'s largest pharmaceutical companies.
 
'''Parasol Pharmaceutical S.p.A''', commonly known as '''Parasol Pharma''', is an Acirian multinational healthcare company that operates worldwide in the pharmaceutical, chemical and biotechnological fields since its founding in 1927. It is currently ran by Salvano Ombrello, the son of the founder of the company. Parasol Pharma is headquartered in Soleramo, [[Aciria]], with its biotechnical division headquartered in [[Trossera]], following the acquisition of DeSantoro Tecnico in 1997, with the majority of manufacturing and R&D sites are located in Aciria. In 2030 the company was acquired by [[Daxia]]'s [[Opdo Corporation]], one of [[Audonia]]'s largest pharmaceutical companies.


==History==
==History==
Line 72: Line 71:
|}
|}


[[Category:Companies]] [[Category:Aciria]]
[[Category:Companies]]
[[Category:Daxia]]
[[Category:Daxia]]
[[Category:IXWB]]
[[Category:IXWB]]

Revision as of 10:53, 19 October 2023

Parasol Pharmaceuticals S.p.A
Company typePrivate
Industry
  • Pharmaceutical
  • Chemical
  • Biotechnology
Founded1927; 97 years ago (1927) in Soleramo
FoundersGiovaldo Ombrello Giardo Carusso
Headquarters
Soleramo
,
Area served
Worldwide
Key people
Salvano Ombrello, CEO
Nivetta Costanari, CFO
Arcanzo Basilvesta, director
Products
  • Pharmaceuticals
  • vaccines
  • medical devices
Revenue (2020)
 (2020)
 (2020)
Total assets (2020)
Number of employees
65,800 (2020)
SubsidiariesUsan Uiyagpum, DeSantoro Tecnico

Parasol Pharmaceutical S.p.A, commonly known as Parasol Pharma, is an Acirian multinational healthcare company that operates worldwide in the pharmaceutical, chemical and biotechnological fields since its founding in 1927. It is currently ran by Salvano Ombrello, the son of the founder of the company. Parasol Pharma is headquartered in Soleramo, Aciria, with its biotechnical division headquartered in Trossera, following the acquisition of DeSantoro Tecnico in 1997, with the majority of manufacturing and R&D sites are located in Aciria. In 2030 the company was acquired by Daxia's Opdo Corporation, one of Audonia's largest pharmaceutical companies.

History

The Parasol Pharma warehouse after its expansion.

The founder of the company, Giovaldo Ombrello, was born in the town of Crotta in Aciria Marini on 17 August 1914. Ombrello's father ran a local fishery.

Ombrello went on to study pharmacy at the University of Marocino, where he graduated from in 1938. Due to the increased demand of pharmaceuticals, Ombrello partnered with Soleramo entrepreneur Giardo Carusso, who he bought out a medical warehouse with in 1940 and founded Parasol Pharmaceuticals two months later. Distributing pharmaceutical ingredients across Santa-Beatrice and soon expanding their business to nearby regions, and eventually having to move out to a larger warehouse and office. It was at this time in 1942 when Cavorio Milando was included in the company, responsible for managing the further expansion of the company. Aciria eventually joining the war made doing business harder for Ombrello and his associates, but it didn't stop them. Closely working with the Imperial Army Medical Corps ensured Ombrello or any of his associates weren't drafted due to their essential part in the company. After the ending of the war, the company expanded by buying out local plants and laboratories that had gone out of business during the war, allowing Parasol Pharma to research and produce their own pharmaceuticals for the first time.

Parasol Pharma made its first overseas acquisition in 2005 with the purchase of Usan Uiyagpum, which manufactures and distributes their products in Metzetta.

Notable products

Trade name Indication
Baramin Attention deficit hyperactivity disorder (ADHD)
BreathEz Asthma, chronic obstructive pulmonary disease
Topixacin Antidepressant
Darvorin Anxiety disorder
Baratrace, Sodinidine Insomnia
Megamara Retrodocin Growth hormone deficiency
Compamax Inflammatory pain